Episode Details

Back to Episodes
Episode 172: ASCO 2022: Adjuvant everolimus in renal cancer

Episode 172: ASCO 2022: Adjuvant everolimus in renal cancer

Season 1 Episode 172 Published 4 years, 4 months ago
Description
Chris Ryan describes the results of this adjuvant study.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us